Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia.
Mol Ther Oncolytics. 2020 Apr 29;17:408-420. doi: 10.1016/j.omto.2020.04.009. eCollection 2020 Jun 26.
Mol Ther Oncolytics. 2020.
PMID: 32462078
Free PMC article.